Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C28H39ClN6O6
CAS Number:
Molecular Weight:
591.10
MDL number:
NACRES:
NA.21
Assay:
≥95%
Form:
solid
Quality Segment
assay
≥95%
form
solid
storage condition
protect from light
color
off-white to pale yellow
storage temp.
−20°C
SMILES string
O=C(N)NCCCC(NC(=O)C(NC(=O)CCCCCN1C(=O)C=CC1=O)C(C)C)C(=O)NC2=CC=C(C=C2)CCl
InChI
1S/C28H39ClN6O6/c1-18(2)25(34-22(36)8-4-3-5-16-35-23(37)13-14-24(35)38)27(40)33-21(7-6-15-31-28(30)41)26(39)32-20-11-9-19(17-29)10-12-20/h9-14,18,21,25H,3-8,15-17H2,1-2H3,(H,32,39)(H,33,40)(H,34,36)(H3,30,31,41)/t21-,25-/m0/s1
InChI key
TUMQZNBKSWFFAZ-OFVILXPXSA-N
General description
Mc-Val-Cit-PAB-Cl is a protease-cleavable linker used in antibody-drug conjugates (ADCs). Specifically, it contains the Val-Cit (valine-citrulline) dipeptide motif, which is cleaved by cathepsin proteases in the lysosome, coupled with a PAB (para-aminobenzyl) carbamate (PAB-Cl indicates PAB with a chloromethyl group) self-immolative spacer, and a terminal chloromethyl phenyl group for conjugation. It’s designed to link the cytotoxic payload (e.g. MMAE) to an antibody, forming an ADC such as MC-VC-PABC-MMAE.
Application
- Antibody-Drug Conjugates (ADCs): A linker component for ADCs, particularly with MMAE (Monomethyl auristatin E), forming ADCs with cytotoxic activity.
- Cancer research: Used in preclinical ADC constructs against tumor cell lines. For example, anti-CD22-MC-VC-PABC-MMAE showing IC₅₀s in BJAB, WSU cell lines.
- Bioconjugation chemistry: Useful as a linker for conjugating antibodies with small molecule payloads.
Features and Benefits
- Cleavable by proteases (Val-Cit motif): Ensures drug release specifically in the target cell lysosome environment.
- Self-immolative spacer (PAB-Cl): After proteolytic cleavage, the PAB spacer facilitates release of free drug.
- Chloromethyl phenyl group: Provides a handle for stable conjugation chemistry to antibodies.
Other Notes
- Protease cleavage: Val-Cit portion is recognized and cleaved by cathepsin enzymes (often cathepsin B) in lysosomes. Amide bond formation: The linker has amide bonds; payloads or antibodies typically conjugate via amine or thiol reactive groups.
- Self-immolative release: After proteolytic trigger, the PAB spacer undergoes spontaneous decomposition to release the drug moiety.
- Sensitivity: Must avoid conditions that degrade the Val-Cit or PAB moieties prematurely (e.g., perhaps strong acids, high temperatures, non-compatible buffers).
signalword
Warning
hcodes
Hazard Classifications
Skin Sens. 1B
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
